Vaccine Enterprise

Global HIV Vaccine Enterprise annual stakeholders meeting: Accelerating early phase vaccine research

IAS – the International AIDS Society

HIVR4P // Virtual 2021 (SA16) How HIV Vaccine R&D is enabling the rapid COVID-19 vaccine response

IAS – the International AIDS Society

Global HIV Vaccine Enterprise Annual Stakeholder Meeting: HIV vaccine cannot be ‘business as usual’

IAS – the International AIDS Society

Enterprise Health Webinar: COVID Vaccine Legalities and Logistical Challenges

Enterprise Health

Vaccine Equity: Developing A Social Enterprise to Bring Imperial's Covid-19 Vaccine to World

Paris Peace Forum

W26052107 Gene signature associating with HIV vaccine efficacy and antibody effector function

IAS – the International AIDS Society

Enterprise Center could become COVID vaccine distribution site

FOX 2 St. Louis

VE-Panel 2B: Future design approaches for HIV vaccine efficacy trials

IAS – the International AIDS Society

One of SA's HIV vaccine clinical trials halted

VE-Panel 3B: Community Engagement and Involvement in HIV Vaccine Prevention Clinical Research

IAS – the International AIDS Society

AIDS VACCINE 2012

Enterprise group works together to fight Biden administration's vaccine mandate

WDHN

Pfizer CEO says Omicron vaccine will be ready in March

Free flu vaccine clinic Tuesday night at Enterprise Center

Part 2: AIDS Vaccine Research and Development Efforts at NIAID

IAVI

Vaccine or COVID-19 test required at Enterprise Center starting Friday

Economic News Today- Omicron Vaccine | Enterprise Products Partners News | Take Two Interactive News

Exencial Wealth Advisors

CommonSpirit Health - Allergies & the COVID-19 Vaccine

CommonSpirit Health Physician Enterprise

Swinging into full gear: Strengthening industry engagement in HIV vaccine research and development

IAS – the International AIDS Society

Biden's vaccine mandate and the public response | IN 60 SECONDS

American Enterprise Institute